Chemical castration with intratesticular injection of 20% hypertonic saline: A minimally invasive method

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 4, 2008, Pages 392-396

  Emir, Levent ^a   Dadali, Mümtaz ^a   Sunay, Melih ^a   Erol, Demokan ^a   Çaydere, Muzaffer ^a   Üstün, Hüseyin ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Castration; Chemoablation; Hypertonic saline; Rats

Indexed keywords

SODIUM CHLORIDE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY IMAGE; CASTRATION; CHEMICAL CASTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; INTERMETHOD COMPARISON; MALE; METASTASIS; MINIMALLY INVASIVE SURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INFECTION; STATISTICAL SIGNIFICANCE; TESTIS; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE; TISSUE NECROSIS;

ANIMALS; GONADOTROPIN-RELEASING HORMONE; INJECTIONS; MALE; ORCHIECTOMY; RATS; SALINE SOLUTION, HYPERTONIC; TESTIS;

EID: 45849118353     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.05.013     Document Type: Article

References (20)

1. Huggins C., Stevens R.E., and Hodges W. Studies on prostate cancer II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 43 (1941) 209-213
2. Lin B.J., Chen K.K., Chen M.T., et al. The time for serum testosterone to reach castrate level after bilateral orchiectomy or oral estrogens in the management of metastatic prostatic cancer. Urology 43 (1994) 834-837
3. Riba L.W. Subcapsular castration for carcinoma of prostate. J Urol 48 (1942) 384-386
4. Bergman B., Damber J.E., and Tomic R. Effects of total and subcapsular orchiectomy on serum concentrations of testosterone and pituitary hormones in patients with carcinoma of prostate. Urol Int 37 (1982) 139-144
5. McDonald J.H., and Calams J.A. Extraparenchymal Leydig-like cells; observations following subcapsular orchiectomy. J Urol 82 (1959) 145-147
6. O'Connor V.J., Chiang S.P., and Grayhack J.T. Is subcapsular orchiectomy a definitive procedure?. Studies of hormone excretion before and after orchiectomy. J Urol 89 (1963) 236-238
7. Clark P., and Houghton L. Subcapsular orchiectomy for carcinoma of the prostate. Br J Urol 49 (1977) 419-425
8. Tacker J.R., Coker J.E., Hosty T.A., et al. Hormonal effect of subcapsular orchiectomy versus total orchiectomy. Invest Urol 17 (1980) 441-442
9. Moorhead D., and Barnes R. Technique for bilateral orchiectomy leaving epididymis. Urology 18 (1981) 294
10. Issa M.M., Lendvay T.S., Bouet R., et al. Epididymal sparing bilateral simple orchiectomy with epididymoplasty: Preservation of esthetics and body image. J Urol 174 (2005) 893-897
11. Auclair C., Kelly P.A., and Labrie F. Inhibition of testicular luteinizing hormone receptor level by treatment with a potent LHRH agonist or human chorionic gonadotropin. Biochem Biophys Res Commun 76 (1977) 855-862
12. Thompson I.M., Zeidman E.J., and Rodriguez F.R. Sudden death due to disease flare with luteinizing hormone releasing agonist therapy for carcinoma of the prostate. J Urol 144 (1990) 1479-1480
13. Massoud W., Paparel P., Lopez J.G., et al. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer. Int J Urol 13 (2006) 87-88
14. Daskivich T.J., and Oh W.K. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms?. Urology 67 (2006) 1084
15. Sakamoto R., Higashi Y., Mera K., et al. Granulomas induced by subcutaneous injection of leuprorelin acetate. J Dermatol 33 (2006) 43-45
16. Grimwood R.E., and Guevara A. Leuprolide acetate-induced dermatitis herpetiformis. Cutis 75 (2005) 49-52
17. Henriksson P., and Edhag O. Orchiectomy versus estrogen for prostate cancer: Cardiovascular effects. Br Med J 293 (1986) 413-415
18. Issa M.M., Krishnan A., Bouet R., et al. The fate of the medically castrated testis: Expectation versus reality. J Urol 172 (2004) 1042-1044
19. McCoy S., Evans A., and Spurrier N. Sclerotherapy for leg telangiectasia: A blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 25 (1999) 381-385
20. Rehman J., Landman J., Sundaram C., et al. Tissue chemoablation. J Endourol 17 (2003) 647-657